Cargando…
Comparing Pioglitazone to Insulin with Respect to Cancer, Cardiovascular and Bone Fracture Endpoints, Using Propensity Score Weights
BACKGROUND: Diabetes is an important global disease, associated with significant morbidity and an increased risk of death due to chronic end-organ complications. The thiazolidinediones, used mainly as third-line agents in type 2 diabetes mellitus (T2DM), have been associated with some safety concern...
Autores principales: | Vallarino, Carlos, Perez, Alfonso, Fusco, Gregory, Liang, Huifang, Bron, Morgan, Manne, Sudhakar, Joseph, Guiandre, Yu, Shawn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751328/ https://www.ncbi.nlm.nih.gov/pubmed/23881565 http://dx.doi.org/10.1007/s40261-013-0106-9 |
Ejemplares similares
-
Weight Trimming and Propensity Score Weighting
por: Lee, Brian K., et al.
Publicado: (2011) -
Comparison of pain-relieving effects by number of irradiations, through propensity score matching and the international consensus endpoint
por: Aoki, Yuki, et al.
Publicado: (2023) -
Propensity score weighting for causal subgroup analysis
por: Yang, Siyun, et al.
Publicado: (2021) -
Post-authorisation Safety Study of Pioglitazone Use and Safety Endpoints of Interest in Denmark After Direct Healthcare Professional Communication
por: Cid Ruzafa, Javier, et al.
Publicado: (2019) -
Concomitant therapy with pioglitazone and insulin for the treatment of type 2 diabetes
por: Yamanouchi, Toshikazu
Publicado: (2010)